You are here: Industry Insights > BARDA

News List

U.S. Invests $472mn More in Moderna contractpharma
July 28, 2020
Expansion of BARDA deal supports mRNA-1273 clinical development plan including 30,000 participant Phase 3 COVE study conducted in collaboration with NIH.
Thermo Fisher Continues Expansion to Support COVID-19 Response contractpharma
July 21, 2020
BARDA provides funding to support the expansion of Thermo Fisher's manufacturing capacity for sterile injectables.
BD Partners with U.S. Govt. on $70M Vaccination Program contractpharma
July 14, 2020
Company finalizes initial pandemic order for 50 million injection devices to support Operation Warp Speed vaccination program.
US awards $450m contract to Regeneron for Covid-19 therapy supply pharmaceutical-technology
July 09, 2020
Regeneron Pharmaceuticals has received a $450m contract from the US Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense for the manufacture and supply of its antibody cocktail therapy against Covid-19.
Regeneron Awarded $450M BARDA Contract contractpharma
July 08, 2020
To manufacture and supply anti-viral antibody cocktail REGN-COV2 for the potential treatment of COVID-19.
FDA Publicly Shares Antibody Test Performance Data from Kits as Part of Validation Study americanpharmaceuticalreview
June 16, 2020
The U.S. Food and Drug Administration (FDA) publicly posted test performance data from four more antibody, or serology, test kits on open.fda.gov from its independent performance validation study effort with the National Institutes of Health’s (NIH) ...
Valor Glass Packaging Selected to Accelerate Delivery of COVID-19 Vaccines contractpharma
June 15, 2020
Corning to receive $204 million in funding to expand domestic manufacturing capacity under White House’s Operation Warp Speed Initiative.
Emergent gets $628m Covid-19 vaccine manufacturing contract pharmaceutical-technology
June 03, 2020
Emergent BioSolutions has secured a $628m contract from the US Biomedical Advanced Research and Development Authority (BARDA) for domestic manufacturing of Covid-19 vaccine candidates.
Phlow secures $354m US contract for drug supply amid Covid-19 pharmaceutical-technology
May 21, 2020
US-based public benefit drug manufacturing corporation Phlow has received $354m funding from the government to produce essential medicines at risk of shortage amid the Covid-19 pandemic.
Sabin and ReiThera Enter Clinical Manufacturing Pact contractpharma
May 15, 2020
BARDA provides the Sabin Vaccine Institute with additional $20mn for further development of Ebola Sudan and Marburg vaccines.

Previous page 1 2 3 4 5 Next page